AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
About AbCellera Biologics Inc. A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation. VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on ...